ISRCTN76146656已完成不适用
What is the most cost effective anti-thrombotic strategy to reduce mortality in heart failure? The WASH Study
Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)0 个研究点目标入组 279 人开始时间: 2004年1月23日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 279
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients were being treated for heart failure, and had evidence of ventricular dysfunction to a defined level on echocardiography.
排除标准
- •Not provided at time of registration
研究者
相似试验
已完成
不适用
*Cost-effectiveness of tailoring anticoagulant therapy by a VTE recurrence prediction model in patients with venous thrombo-embolism as compared to care-as-usual: the VISTA study.*Pulmonary EmbolismDeep Venous Thrombosis1003745410014523NL-OMON41715niversitair Medisch Centrum Utrecht968
尚未招募
Unknown
Optimal antithrombotic strategy for treatment of atherosclerotic cardiovascular disease – comparison of clopidogrel-based antiplatelet agent treatment versus aspirin plus low dose rivaroxaban therapy (OACART study)KCT0008458Seoul National University Bundang Hospital2,758
已完成
不适用
Appropriateness of Antithrombotic agents use in stroke patients with atrial fibrillation in KoreaKCT0000244Seoul National University Bundang Hospital3,000
已完成
不适用
Multicenter Registry for the Optimal Antithrombotic Therapy in the Patients with Arial Fibrillation Undergoing Percutaneous Coronary Intervention StudyAtrial fibrillation Coronary artery diseaseJPRN-UMIN000015531Department of Cardiovascular Medicine, Kitasato University School of Medicine100
撤回
4 期
What is the optimal antithrombotic strategy in patients presenting with acute coronary syndrome having atrial fibrillation with indication for anticoagulants?myocardial infarctionNL-OMON49131Sint Antonius Ziekenhuis2,500